Novel lipoprotein subfraction and size measurements in prediction of mortality in maintenance hemodialysis patients

Clinical Journal of the American Society of Nephrology

Volumn 6, Issue 12, 2011, Pages 2861-2870

  Noori, Nazanin ^a   Caulfield, Michael P ^b   Salameh, Wael A ^b   Reitz, Richard E ^b   Nicholas, Susanne B ^c   Molnar, Miklos Z ^a,d   Nissenson, Allen R ^e   Kovesdy, Csaba P ^f,g   Kalantar Zadeh, Kamyar ^a,c,h  

^a HARBOR UCLA MEDICAL CENTER   (United States)

^b QUEST DIAGNOSTICS NICHOLS INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SEMMELWEIS UNIVERSITY   (Hungary)

^e DAVITA INC   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF VIRGINIA   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PREALBUMIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BIOCHEMISTRY; CHOLESTEROL BLOOD LEVEL; CONCENTRATION (PARAMETERS); HEMODIALYSIS PATIENT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOASSAY; LABORATORY TEST; LIPID ANALYSIS; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PARTICLE SIZE; PREDICTOR VARIABLE; RISK ASSESSMENT;

ADULT; AGED; BODY MASS INDEX; CHOLESTEROL, HDL; CHOLESTEROL, LDL; FEMALE; HUMANS; MALE; MIDDLE AGED; PARTICLE SIZE; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS;

EID: 83155175910     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.03650411     Document Type: Article

References (31)

1. United States Renal Data System (USRDS). USRDS 2010 Annual Data Report. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
2. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 106: 3143-3421, 2002
3. Kilpatrick RD, McAllister CJ, Kovesdy CP, Derose SF, Kopple JD, Kalantar-Zadeh K: Association between serum lipids and survival in hemodialysis patients and impact of race. J Am Soc Nephrol 18: 293-303, 2007
4. Iseki K, Yamazato M, Tozawa M, Takishita S: Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 61: 1887-1893, 2002
5. Liu Y, Coresh J, Eustace JA, Longenecker JC, Jaar B, Fink NE, Tracy RP, Powe NR, Klag MJ: Association between cholesterol level and mortality in dialysis patients: Role of inflammation and malnutrition. JAMA 291: 451-459, 2004
6. Kovesdy CP, Anderson JE, Kalantar-Zadeh K: Inverse association between lipid levels and mortality in men with chronic kidney disease who are not yet on dialysis: Effects of case mix and the malnutrition-inflammation-cachexia syndrome. J Am Soc Nephrol 18: 304-311, 2007
7. Musliner TA, Krauss RM: Lipoprotein subspecies and risk of coronary disease. Clin Chem 34: B78-B83, 1988
8. Ip S, Lichtenstein AH, Chung M, Lau J, Balk EM: Systematic review: Association of low-density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med 150: 474-484, 2009
9. Asztalos BF, Collins D, Cupples LA, Demissie S, Horvath KV, Bloomfield HE, Robins SJ, Schaefer EJ: Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention Trial. Arterioscler Thromb Vasc Biol 25: 2185-2191, 2005
10. Mora S, Otvos JD, Rifai N, Rosenson RS, Buring JE, Ridker PM: Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women. Circulation 119: 931-939, 2009
11. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE: Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women. JAMA 294: 326-333, 2005
12. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS: Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. JAMA 298: 776-785, 2007
13. McQueen MJ, Hawken S, Wang X, Ounpuu S, Sniderman A, Probstfield J, Steyn K, Sanderson JE, Hasani M, Volkova E, Kazmi K, Yusuf S: Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): A case-control study. Lancet 372: 224-233, 2008
14. Caulfield MP, Li S, Lee G, Blanche PJ, Salameh WA, Benner WH, Reitz RE, Krauss RM: Direct determination of lipoprotein particle sizes and concentrations by ion mobility analysis. Clin Chem 54: 1307-1316, 2008
15. Otvos JD, Rudel LL, McConnell JP: Concerns regarding lipoprotein particle measurement by ion mobility analysis. Clin Chem 54: 2086-2087; author reply 2088-2089, 2008
16. Colman S, Bross R, Benner D, Chow J, Braglia A, Arzaghi J, Dennis J, Martinez L, Baldo DB, Agarwal V, Trundnowski T, Zitterkoph J, Martinez B, Khawar OS, Kalantar-Zadeh K: The Nutritional and Inflammatory Evaluation in Dialysis patients (NIED) study: Overview of the NIED study and the role of dietitians. J Ren Nutr 15: 231-243, 2005
17. Noori N, Kalantar-Zadeh K, Kovesdy CP, Murali SB, Bross R, Nissenson AR, Kopple JD: Dietary potassium intake and mortality in long-term hemodialysis patients. Am J Kidney Dis 56: 338-347, 2010
18. Noori N, Kopple JD, Kovesdy CP, Feroze U, Sim JJ, Murali SB, Luna A, Gomez M, Luna C, Bross R, Nissenson AR, Kalantar-Zadeh K: Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 5: 2258-2268, 2010
19. Noori N, Kovesdy CP, Dukkipati R, Kim Y, Duong U, Bross R, Oreopoulos A, Luna A, Benner D, Kopple JD, Kalantar-Zadeh K: Survival predictability of lean and fat mass in men and women undergoing maintenance hemodialysis. Am J Clin Nutr 92: 1060-1070, 2010
20. Bross R, Chandramohan G, Kovesdy CP, Oreopoulos A, Noori N, Golden S, Benner D, Kopple JD, Kalantar-Zadeh K: Comparing body composition assessment tests in longterm hemodialysis patients. Am J Kidney Dis 55: 885-896, 2010
21. Miller JE, Kovesdy CP, Nissenson AR, Mehrotra R, Streja E, Van Wyck D, Greenland S, Kalantar-Zadeh K: Association of hemodialysis treatment time and dose with mortality and the role of race and sex. Am J Kidney Dis 55: 100-112, 2010
22. Rambod M, Kovesdy CP, Kalantar-Zadeh K: Combined high serum ferritin and low iron saturation in hemodialysis patients: The role of inflammation. Clin J Am Soc Nephrol 3: 1691-1701, 2008
23. Rambod M, Kovesdy CP, Bross R, Kopple JD, Kalantar-Zadeh K: Association of serum prealbumin and its changes over time with clinical outcomes and survival in patients receiving hemodialysis. Am J Clin Nutr 88: 1485-1494, 2008
24. Durrleman S, Simon R: Flexible regression models with cubic splines. Stat Med 8: 551-561, 1989
25. Lowrie EG, Lew NL: Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15: 458-482, 1990
26. Kalantar-Zadeh K, Kopple JD, Kamranpour N, Fogelman AM, Navab M: HDL-inflammatory index correlates with poor outcome in hemodialysis patients. Kidney Int 72: 1149-1156, 2007
27. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 285: 2486-2497, 2001
28. Otvos J, Cromwell W, Shalaurova I, et al.: LDL particles, but not LDL cholesterol, are highly elevated in the metabolic syndrome: Results from the Framingham Offspring Study [abstract]. Circulation 108: (Suppl.):740-744, 2003
29. Cromwell WC, Otvos JD: Low-density lipoprotein particle number and risk for cardiovascular disease. Curr Atheroscler Rep 6: 381-387, 2004
30. Kovesdy CP, Kalantar-Zadeh K: Why is protein-energy wasting associated with mortality in chronic kidney disease? Semin Nephrol 29: 3-14,2009
31. Kalantar-Zadeh K, Kilpatrick RD, Kopple JD, Stringer WW: A matched comparison of serum lipids between hemodialysis patients and nondialysis morbid controls. Hemodial Int 9: 314-324, 2005